These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 27890770

  • 21. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
    Kinoshita T, Ishikawa Y, Arita M, Akishima-Fukasawa Y, Fujita K, Inomata N, Suzuki T, Namiki A, Mikami T, Ikeda T, Yamazaki J, Ishii T, Akasaka Y.
    Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
    [Abstract] [Full Text] [Related]

  • 22. Connective tissue growth factor and bone morphogenetic protein 2 are induced following myocardial ischemia in mice and humans.
    Rutkovskiy A, Sagave J, Czibik G, Baysa A, Zihlavnikova Enayati K, Hillestad V, Dahl CP, Fiane A, Gullestad L, Gravning J, Ahmed S, Attramadal H, Valen G, Vaage J.
    Scand J Clin Lab Invest; 2017 Sep; 77(5):321-331. PubMed ID: 28460577
    [Abstract] [Full Text] [Related]

  • 23. Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy.
    Nakano SJ, Miyamoto SD, Movsesian M, Nelson P, Stauffer BL, Sucharov CC.
    Circ Heart Fail; 2015 Jan; 8(1):57-63. PubMed ID: 25278000
    [Abstract] [Full Text] [Related]

  • 24. Heterogeneous transmural distribution of beta-adrenergic receptor subtypes in failing human hearts.
    Beau SL, Tolley TK, Saffitz JE.
    Circulation; 1993 Dec; 88(6):2501-9. PubMed ID: 7902783
    [Abstract] [Full Text] [Related]

  • 25. High prevalence of atrial fibrosis in patients with dilated cardiomyopathy.
    Ohtani K, Yutani C, Nagata S, Koretsune Y, Hori M, Kamada T.
    J Am Coll Cardiol; 1995 Apr; 25(5):1162-9. PubMed ID: 7897130
    [Abstract] [Full Text] [Related]

  • 26. Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation.
    Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu EW.
    NMR Biomed; 2014 Nov; 27(11):1378-86. PubMed ID: 25200106
    [Abstract] [Full Text] [Related]

  • 27. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure.
    Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, Al Batran R, Pherwani S, Ho KL, Boisvenue J, Karwi QG, Altamimi T, Wishart DS, Dyck JRB, Ussher JR, Oudit GY, Lopaschuk GD.
    Cardiovasc Diabetol; 2019 Jul 05; 18(1):86. PubMed ID: 31277657
    [Abstract] [Full Text] [Related]

  • 28. Lipomatous metaplasia in left ventricular scar.
    Baroldi G, Silver MD, De Maria R, Parodi O, Pellegrini A.
    Can J Cardiol; 1997 Jan 05; 13(1):65-71. PubMed ID: 9039067
    [Abstract] [Full Text] [Related]

  • 29. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy.
    de Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM.
    Transpl Int; 2001 Sep 05; 14(5):299-306. PubMed ID: 11692213
    [Abstract] [Full Text] [Related]

  • 30. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts.
    Zhao S, Wu H, Xia W, Chen X, Zhu S, Zhang S, Shao Y, Ma W, Yang D, Zhang J.
    J Cardiol; 2014 May 05; 63(5):373-8. PubMed ID: 24219836
    [Abstract] [Full Text] [Related]

  • 31. Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy.
    Chaffin M, Papangeli I, Simonson B, Akkad AD, Hill MC, Arduini A, Fleming SJ, Melanson M, Hayat S, Kost-Alimova M, Atwa O, Ye J, Bedi KC, Nahrendorf M, Kaushik VK, Stegmann CM, Margulies KB, Tucker NR, Ellinor PT.
    Nature; 2022 Aug 05; 608(7921):174-180. PubMed ID: 35732739
    [Abstract] [Full Text] [Related]

  • 32. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy.
    Yokoseki O, Yazaki Y, Suzuki J, Imamura H, Takenaka H, Isobe M.
    Jpn Circ J; 2000 May 05; 64(5):352-7. PubMed ID: 10834450
    [Abstract] [Full Text] [Related]

  • 33. Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age.
    Antonov IB, Kozlov KL, Pal'tseva EM, Polyakova OV, Lin'kova NS.
    Bull Exp Biol Med; 2018 Mar 05; 164(4):550-553. PubMed ID: 29504111
    [Abstract] [Full Text] [Related]

  • 34. Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy.
    Waller TA, Hiser WL, Capehart JE, Roberts WC.
    Am J Cardiol; 1998 Apr 01; 81(7):884-94. PubMed ID: 9555779
    [Abstract] [Full Text] [Related]

  • 35. Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2.
    Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR, Canver CC.
    Circulation; 2003 Oct 07; 108(14):1707-12. PubMed ID: 14504186
    [Abstract] [Full Text] [Related]

  • 36. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.
    Li YY, Feldman AM, Sun Y, McTiernan CF.
    Circulation; 1998 Oct 27; 98(17):1728-34. PubMed ID: 9788826
    [Abstract] [Full Text] [Related]

  • 37. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts.
    Linck B, Bokník P, Eschenhagen T, Müller FU, Neumann J, Nose M, Jones LR, Schmitz W, Scholz H.
    Cardiovasc Res; 1996 Apr 27; 31(4):625-32. PubMed ID: 8689655
    [Abstract] [Full Text] [Related]

  • 38. Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients.
    Batlle M, Pérez-Villa F, García-Pras E, Lázaro A, Orús J, Roqué M, Roig E.
    Transplant Proc; 2007 Sep 27; 39(7):2344-6. PubMed ID: 17889183
    [Abstract] [Full Text] [Related]

  • 39. Myocardial transcriptome analysis of human arrhythmogenic right ventricular cardiomyopathy.
    Gaertner A, Schwientek P, Ellinghaus P, Summer H, Golz S, Kassner A, Schulz U, Gummert J, Milting H.
    Physiol Genomics; 2012 Jan 18; 44(1):99-109. PubMed ID: 22085907
    [Abstract] [Full Text] [Related]

  • 40. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.
    Fedak PW, Moravec CS, McCarthy PM, Altamentova SM, Wong AP, Skrtic M, Verma S, Weisel RD, Li RK.
    Circulation; 2006 Jan 17; 113(2):238-45. PubMed ID: 16401770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.